These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 39089446)

  • 1. Temporal effects of lascufloxacin on human gut and salivary microbiota: Analysis using next-generation sequencing method.
    Mukuda K; Inoue R; Takata M; Takazawa K; Noma H; Morishima S; Oda M; Ma'arif AS; Endo Y; Sunada H; Doi A; Matsuda R; Nishikawa Y; Okada K; Kitaura T; Nakamoto M; Yamasaki A; Chikumi H
    J Infect Chemother; 2024 Jul; ():. PubMed ID: 39089446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Drip Infusion of Lascufloxacin, a Novel Fluoroquinolone Antibiotic, for Patients with Pneumonia Including Chronic Lung Disease Exacerbations and Lung Abscesses.
    Shimada D; Seki M
    Infect Drug Resist; 2024; 17():911-918. PubMed ID: 38476768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of lascufloxacin for nursing- and healthcare-associated pneumonia: A single-arm, open-label clinical trial.
    Takazono T; Hosogaya N; Fukushima K; Morio R; Irifune S; Miyamura T; Harada Y; Nagayoshi Y; Kondo A; Mihara T; Fukuda Y; Sasaki E; Sawai T; Imamura Y; Morikawa T; Futsuki Y; Inoue Y; Fukushima K; Suyama N; Tanaka H; Hanaka T; Shimabukuro I; Hata R; Ota K; Morimoto S; Nakada N; Ito Y; Yoshida M; Takeda K; Ide S; Iwanaga N; Nemoto K; Funada M; Izumikawa K; Yatera K; Yanagihara K; Mukae H
    J Infect Chemother; 2024 Jul; 30(7):597-602. PubMed ID: 38190963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the dynamic changes in gut microbiota in patients with extremely severe burns by 16S ribosomal RNA high-throughput sequencing technology].
    Pan YY; Fan YF; Li JL; Cui SY; Huang N; Jin GY; Chen C; Zhang C
    Zhonghua Shao Shang Za Zhi; 2020 Dec; 36(12):1159-1166. PubMed ID: 33379852
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic study of lascufloxacin in non-elderly healthy men and elderly men.
    Totsuka K; Sesoko S; Fukase H; Ikushima I; Odajima M; Niwayama Y
    J Infect Chemother; 2020 Mar; 26(3):231-239. PubMed ID: 31882385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three cases of hospitalized Legionella pneumonia patients successfully treated with lascufloxacin.
    Ito A; Kawataki M; Sato R; Nakanishi Y; Ishida T
    J Infect Chemother; 2024 May; ():. PubMed ID: 38815654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary and fecal microbiota: potential new biomarkers for early screening of colorectal polyps.
    Zhang L; Feng Z; Li Y; Lv C; Li C; Hu Y; Fu M; Song L
    Front Microbiol; 2023; 14():1182346. PubMed ID: 37655344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between childhood obesity and gut microbiota: 16S rRNA gene sequencing-based cohort study.
    Li XM; Lv Q; Chen YJ; Yan LB; Xiong X
    World J Gastroenterol; 2024 Apr; 30(16):2249-2257. PubMed ID: 38690025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Spatial Features and Temporal Changes in the Gut Microbiota of a Healthy Chinese Population.
    Zhang W; Han N; Zhang T; Qiang Y; Peng X; Li X; Kan B
    Microbiol Spectr; 2022 Dec; 10(6):e0131022. PubMed ID: 36453887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using 16S rDNA and metagenomic sequencing technology to analyze the fecal microbiome of children with avoidant/restrictive food intake disorder.
    Ye Q; Sun S; Deng J; Chen X; Zhang J; Lin S; Du H; Gao J; Zou X; Lin X; Cai Y; Lu Z
    Sci Rep; 2023 Nov; 13(1):20253. PubMed ID: 37985845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of efficacy and safety of lascufloxacin for nursing and healthcare associated pneumonia: single-arm, open-label clinical trial: A study protocol.
    Hosogaya N; Takazono T; Ota K; Kiya R; Shirai Y; Kawasaki R; Yano H; Morimoto S; Nakao R; Kanamaru Y; Yoshino Y; Ishikawa Y; Fukushima C; Yamamoto H; Izumikawa K; Yanagihara K; Mukae H
    Medicine (Baltimore); 2023 Feb; 102(8):e33092. PubMed ID: 36827005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-significant influence between aerobic and anaerobic sample transport materials on gut (fecal) microbiota in healthy and fat-metabolic disorder Thai adults.
    Tunsakul N; Wongsaroj L; Janchot K; Pongpirul K; Somboonna N
    PeerJ; 2024; 12():e17270. PubMed ID: 38650647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of intestinal patients' flora changes with severe pneumonia based on 16SrDNA sequencing technology].
    Zhang X; Yang X; Zhang Z; Lei M; Zhang X; Wang X; Yang X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Dec; 31(12):1479-1484. PubMed ID: 32029033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association between obesity with the diversity and genus of gut microbiota in school-aged children].
    Jiang LF; Wang YY; Peng H; Li R; Zhang F; Wang N; Shao QW; Jiang Q
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Feb; 43(2):260-268. PubMed ID: 35184494
    [No Abstract]   [Full Text] [Related]  

  • 15. Gut Microbiota Composition in Long-Remission Ulcerative Colitis is Close to a Healthy Gut Microbiota.
    Herrera-deGuise C; Varela E; Sarrabayrouse G; Pozuelo Del Río M; Alonso VR; Sainz NB; Casellas F; Mayorga LF; Manichanh C; Vidaur FA; Guarner F
    Inflamm Bowel Dis; 2023 Sep; 29(9):1362-1369. PubMed ID: 37655859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral microbiome alterations of healthy volunteers with proton pump inhibitor.
    Mishiro T; Oka K; Kuroki Y; Takahashi M; Tatsumi K; Saitoh T; Tobita H; Ishimura N; Sato S; Ishihara S; Sekine J; Wada K; Kinoshita Y
    J Gastroenterol Hepatol; 2018 May; 33(5):1059-1066. PubMed ID: 29105152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A healthy dietary pattern is associated with microbiota diversity in recently diagnosed bipolar patients: The Bipolar Netherlands Cohort (BINCO) study.
    Riedinger MA; Mesbah R; Koenders M; Henderickx JGE; Smits WK; El Filali E; Geleijnse JM; van der Wee NJA; de Leeuw M; Giltay EJ
    J Affect Disord; 2024 Jun; 355():157-166. PubMed ID: 38527529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter-site and interpersonal diversity of salivary and tongue microbiomes, and the effect of oral care tablets.
    Maruyama H; Masago A; Nambu T; Mashimo C; Takahashi K; Okinaga T
    F1000Res; 2020; 9():1477. PubMed ID: 33732447
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of type 2 diabetes and metformin on salivary microbiota in patients with chronic periodontitis.
    Gu M; Wang P; Xiang S; Xu D; Jin C; Jiang Z; Hu N
    Microb Pathog; 2021 Dec; 161(Pt B):105277. PubMed ID: 34740808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of salivary microbiota in children with obstructive sleep apnea: A prospective study with polysomnography.
    Huang X; Chen X; Gong X; Xu Y; Xu Z; Gao X
    Front Cell Infect Microbiol; 2022; 12():945284. PubMed ID: 36105146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.